Leonteq Securities’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Leonteq Securities's INMB Position: Q3 2026 in Review
Leonteq Securities held its INmune Bio (INMB) position steady in Q3 2026 at 2,500 shares worth $4.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.
Leonteq Securities first reported a position in INMB in Q3 2021 and has held it in 21 quarters since. The position peaked at $33.6K in Q2 2022. 46 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Leonteq Securities held 2,500 shares of INmune Bio worth $4.88K as of Q3 2026.
- Leonteq Securities left its INmune Bio share count unchanged in Q3 2026.
- INmune Bio made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1085 holding.
- Leonteq Securities first reported a position in INmune Bio in Q3 2021 and has held it in 21 quarters since.
- Leonteq Securities's INmune Bio position peaked at $33.6K in Q2 2022.
- 46 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.